Ligand Pharmaceuticals Statistics
Total Valuation
Herbalife has a market cap or net worth of $930.88 million. The enterprise value is $3.00 billion.
Important Dates
The next confirmed earnings date is Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Herbalife has 101.85 million shares outstanding. The number of shares has increased by 1.65% in one year.
| Current Share Class | 101.85M |
| Shares Outstanding | 101.85M |
| Shares Change (YoY) | +1.65% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 2.20% |
| Owned by Institutions (%) | 90.13% |
| Float | 84.95M |
Valuation Ratios
The trailing PE ratio is 3.33 and the forward PE ratio is 4.50.
| PE Ratio | 3.33 |
| Forward PE | 4.50 |
| PS Ratio | 0.19 |
| Forward PS | 0.18 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.66 |
| P/OCF Ratio | 3.42 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 4.82, with an EV/FCF ratio of 18.26.
| EV / Earnings | 10.71 |
| EV / Sales | 0.61 |
| EV / EBITDA | 4.82 |
| EV / EBIT | 6.01 |
| EV / FCF | 18.26 |
Financial Position
The company has a current ratio of 0.97
| Current Ratio | 0.97 |
| Quick Ratio | 0.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.53 |
| Debt / FCF | 14.60 |
| Interest Coverage | 2.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 11.72% |
| Return on Invested Capital (ROIC) | 19.31% |
| Return on Capital Employed (ROCE) | 32.14% |
| Revenue Per Employee | $575,640 |
| Profits Per Employee | $32,605 |
| Employee Count | 8,600 |
| Asset Turnover | 1.86 |
| Inventory Turnover | 5.46 |
Taxes
| Income Tax | -74.20M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.57% in the last 52 weeks. The beta is 0.89, so Herbalife's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | -25.57% |
| 50-Day Moving Average | 8.69 |
| 200-Day Moving Average | 7.61 |
| Relative Strength Index (RSI) | 48.12 |
| Average Volume (20 Days) | 1,873,943 |
Short Selling Information
The latest short interest is 13.19 million, so 12.95% of the outstanding shares have been sold short.
| Short Interest | 13.19M |
| Short Previous Month | 14.12M |
| Short % of Shares Out | 12.95% |
| Short % of Float | 15.53% |
| Short Ratio (days to cover) | 7.28 |
Income Statement
In the last 12 months, Herbalife had revenue of $4.95 billion and earned $280.40 million in profits. Earnings per share was $2.74.
| Revenue | 4.95B |
| Gross Profit | 2.25B |
| Operating Income | 499.90M |
| Pretax Income | 133.10M |
| Net Income | 280.40M |
| EBITDA | 622.80M |
| EBIT | 499.90M |
| Earnings Per Share (EPS) | $2.74 |
Full Income StatementBalance Sheet
The company has $329.40 million in cash and $2.40 billion in debt, giving a net cash position of -$2.07 billion or -$20.34 per share.
| Cash & Cash Equivalents | 329.40M |
| Total Debt | 2.40B |
| Net Cash | -2.07B |
| Net Cash Per Share | -$20.34 |
| Equity (Book Value) | -736.00M |
| Book Value Per Share | -7.24 |
| Working Capital | -35.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $271.80 million and capital expenditures -$107.40 million, giving a free cash flow of $164.40 million.
| Operating Cash Flow | 271.80M |
| Capital Expenditures | -107.40M |
| Free Cash Flow | 164.40M |
| FCF Per Share | $1.61 |
Full Cash Flow StatementMargins
Gross margin is 45.38%, with operating and profit margins of 10.10% and 5.66%.
| Gross Margin | 45.38% |
| Operating Margin | 10.10% |
| Pretax Margin | 4.17% |
| Profit Margin | 5.66% |
| EBITDA Margin | 12.58% |
| EBIT Margin | 10.10% |
| FCF Margin | 3.32% |
Dividends & Yields
Herbalife does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.65% |
| Shareholder Yield | -1.65% |
| Earnings Yield | 30.12% |
| FCF Yield | 17.66% |
Dividend DetailsAnalyst Forecast
The average price target for Herbalife is $11.50, which is 25.82% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.50 |
| Price Target Difference | 25.82% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 15, 2018. It was a forward split with a ratio of 2:1.
| Last Split Date | May 15, 2018 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Herbalife has an Altman Z-Score of 2.2 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.2 |
| Piotroski F-Score | 5 |
